MENOTROPINS

Other

Brand names: Menopur

Pregnancy: Category XOral

Mechanism of Action

12.1 Mechanism of Action MENOPUR, administered for 7 to 20 days, produces ovarian follicular growth and maturation in women who do not have primary ovarian failure. Treatment with MENOPUR in most instances results only in follicular growth and maturation. When sufficient follicular maturation has occurred, hCG must be given to induce ovulation.

Indications

and diagnose the cause of infertility Exclude the possibility of pregnancy Evaluate the fertility status of the male partner Exclude a diagnosis of primary ovarian failure

Contraindications

• or if the woman becomes pregnant while taking this drug
• the woman should be apprised of the potential hazard to a fetus. Presence of uncontrolled non-gonadal endocrinopathies (e.g.
• thyroid
• adrenal
• not due to polycystic ovary syndrome ( 4 )

FDA Warnings

5 WARNINGS AND PRECAUTIONS MENOPUR should only be used by physicians who are experienced in infertility treatment
MENOPUR contains gonadotropic substances capable of causing in women, Ovarian Hyperstimulation Syndrome (OHSS) with or without pulmonary or vascular complications [see Warnings and Precautions (5
3) ] and multiple births [see Warnings and Precautions (5
Gonadotropin therapy requires the availability of appropriate monitoring facilities [see Warnings and Precautions (5

Known Side Effects

9 documented side effects by frequency

Drug Not Working

1-10%

Injection Site Pain

1-10%

Headache

1-10%

Nausea

1-10%

Abdominal Pain

1-10%

Shortness of Breath

0.1-1%

Fatigue

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

Community Discussions

No community discussions found for MENOTROPINS yet.

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Oral